1 Market Overview of Innovative Drug 1.1 Innovative Drug Market Overview 1.1.1 Innovative Drug Product Scope 1.1.2 Innovative Drug Market Status and Outlook 1.2 Global Innovative Drug Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Innovative Drug Market Size by Region (2016-2027) 1.4 Global Innovative Drug Historic Market Size by Region (2016-2021) 1.5 Global Innovative Drug Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Innovative Drug Market Size (2016-2027) 1.6.1 North America Innovative Drug Market Size (2016-2027) 1.6.2 Europe Innovative Drug Market Size (2016-2027) 1.6.3 Asia-Pacific Innovative Drug Market Size (2016-2027) 1.6.4 Latin America Innovative Drug Market Size (2016-2027) 1.6.5 Middle East & Africa Innovative Drug Market Size (2016-2027) 2 Innovative Drug Market Overview by Type 2.1 Global Innovative Drug Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Innovative Drug Historic Market Size by Type (2016-2021) 2.3 Global Innovative Drug Forecasted Market Size by Type (2022-2027) 2.4 Biological Medicine 2.5 Chemical Medicine 3 Innovative Drug Market Overview by Application 3.1 Global Innovative Drug Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Innovative Drug Historic Market Size by Application (2016-2021) 3.3 Global Innovative Drug Forecasted Market Size by Application (2022-2027) 3.4 Hospitals and Clinics 3.5 Pharmacy 3.6 Others 4 Innovative Drug Competition Analysis by Players 4.1 Global Innovative Drug Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Innovative Drug as of 2020) 4.3 Date of Key Players Enter into Innovative Drug Market 4.4 Global Top Players Innovative Drug Headquarters and Area Served 4.5 Key Players Innovative Drug Product Solution and Service 4.6 Competitive Status 4.6.1 Innovative Drug Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Pfizer 5.1.1 Pfizer Profile 5.1.2 Pfizer Main Business 5.1.3 Pfizer Innovative Drug Products, Services and Solutions 5.1.4 Pfizer Innovative Drug Revenue (US$ Million) & (2016-2021) 5.1.5 Pfizer Recent Developments 5.2 Roche 5.2.1 Roche Profile 5.2.2 Roche Main Business 5.2.3 Roche Innovative Drug Products, Services and Solutions 5.2.4 Roche Innovative Drug Revenue (US$ Million) & (2016-2021) 5.2.5 Roche Recent Developments 5.3 Sanofi 5.5.1 Sanofi Profile 5.3.2 Sanofi Main Business 5.3.3 Sanofi Innovative Drug Products, Services and Solutions 5.3.4 Sanofi Innovative Drug Revenue (US$ Million) & (2016-2021) 5.3.5 Johnson & Johnson Recent Developments 5.4 Johnson & Johnson 5.4.1 Johnson & Johnson Profile 5.4.2 Johnson & Johnson Main Business 5.4.3 Johnson & Johnson Innovative Drug Products, Services and Solutions 5.4.4 Johnson & Johnson Innovative Drug Revenue (US$ Million) & (2016-2021) 5.4.5 Johnson & Johnson Recent Developments 5.5 Merck & Co. (MSD) 5.5.1 Merck & Co. (MSD) Profile 5.5.2 Merck & Co. (MSD) Main Business 5.5.3 Merck & Co. (MSD) Innovative Drug Products, Services and Solutions 5.5.4 Merck & Co. (MSD) Innovative Drug Revenue (US$ Million) & (2016-2021) 5.5.5 Merck & Co. (MSD) Recent Developments 5.6 Novartis 5.6.1 Novartis Profile 5.6.2 Novartis Main Business 5.6.3 Novartis Innovative Drug Products, Services and Solutions 5.6.4 Novartis Innovative Drug Revenue (US$ Million) & (2016-2021) 5.6.5 Novartis Recent Developments 5.7 AbbVie 5.7.1 AbbVie Profile 5.7.2 AbbVie Main Business 5.7.3 AbbVie Innovative Drug Products, Services and Solutions 5.7.4 AbbVie Innovative Drug Revenue (US$ Million) & (2016-2021) 5.7.5 AbbVie Recent Developments 5.8 Gilead Sciences 5.8.1 Gilead Sciences Profile 5.8.2 Gilead Sciences Main Business 5.8.3 Gilead Sciences Innovative Drug Products, Services and Solutions 5.8.4 Gilead Sciences Innovative Drug Revenue (US$ Million) & (2016-2021) 5.8.5 Gilead Sciences Recent Developments 5.9 GlaxoSmithKline (GSK) 5.9.1 GlaxoSmithKline (GSK) Profile 5.9.2 GlaxoSmithKline (GSK) Main Business 5.9.3 GlaxoSmithKline (GSK) Innovative Drug Products, Services and Solutions 5.9.4 GlaxoSmithKline (GSK) Innovative Drug Revenue (US$ Million) & (2016-2021) 5.9.5 GlaxoSmithKline (GSK) Recent Developments 5.10 Amgen 5.10.1 Amgen Profile 5.10.2 Amgen Main Business 5.10.3 Amgen Innovative Drug Products, Services and Solutions 5.10.4 Amgen Innovative Drug Revenue (US$ Million) & (2016-2021) 5.10.5 Amgen Recent Developments 5.11 AstraZeneca 5.11.1 AstraZeneca Profile 5.11.2 AstraZeneca Main Business 5.11.3 AstraZeneca Innovative Drug Products, Services and Solutions 5.11.4 AstraZeneca Innovative Drug Revenue (US$ Million) & (2016-2021) 5.11.5 AstraZeneca Recent Developments 5.12 Bristol-Myers Squibb 5.12.1 Bristol-Myers Squibb Profile 5.12.2 Bristol-Myers Squibb Main Business 5.12.3 Bristol-Myers Squibb Innovative Drug Products, Services and Solutions 5.12.4 Bristol-Myers Squibb Innovative Drug Revenue (US$ Million) & (2016-2021) 5.12.5 Bristol-Myers Squibb Recent Developments 5.13 Eli Lilly 5.13.1 Eli Lilly Profile 5.13.2 Eli Lilly Main Business 5.13.3 Eli Lilly Innovative Drug Products, Services and Solutions 5.13.4 Eli Lilly Innovative Drug Revenue (US$ Million) & (2016-2021) 5.13.5 Eli Lilly Recent Developments 5.14 Teva 5.14.1 Teva Profile 5.14.2 Teva Main Business 5.14.3 Teva Innovative Drug Products, Services and Solutions 5.14.4 Teva Innovative Drug Revenue (US$ Million) & (2016-2021) 5.14.5 Teva Recent Developments 5.15 Bayer 5.15.1 Bayer Profile 5.15.2 Bayer Main Business 5.15.3 Bayer Innovative Drug Products, Services and Solutions 5.15.4 Bayer Innovative Drug Revenue (US$ Million) & (2016-2021) 5.15.5 Bayer Recent Developments 5.16 Novo Nordisk 5.16.1 Novo Nordisk Profile 5.16.2 Novo Nordisk Main Business 5.16.3 Novo Nordisk Innovative Drug Products, Services and Solutions 5.16.4 Novo Nordisk Innovative Drug Revenue (US$ Million) & (2016-2021) 5.16.5 Novo Nordisk Recent Developments 5.17 Allergan 5.17.1 Allergan Profile 5.17.2 Allergan Main Business 5.17.3 Allergan Innovative Drug Products, Services and Solutions 5.17.4 Allergan Innovative Drug Revenue (US$ Million) & (2016-2021) 5.17.5 Allergan Recent Developments 5.18 Takeda 5.18.1 Takeda Profile 5.18.2 Takeda Main Business 5.18.3 Takeda Innovative Drug Products, Services and Solutions 5.18.4 Takeda Innovative Drug Revenue (US$ Million) & (2016-2021) 5.18.5 Takeda Recent Developments 5.19 Boehringer Ingelheim 5.19.1 Boehringer Ingelheim Profile 5.19.2 Boehringer Ingelheim Main Business 5.19.3 Boehringer Ingelheim Innovative Drug Products, Services and Solutions 5.19.4 Boehringer Ingelheim Innovative Drug Revenue (US$ Million) & (2016-2021) 5.19.5 Boehringer Ingelheim Recent Developments 6 North America 6.1 North America Innovative Drug Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Innovative Drug Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Innovative Drug Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Innovative Drug Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Innovative Drug Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Innovative Drug Market Dynamics 11.1 Innovative Drug Industry Trends 11.2 Innovative Drug Market Drivers 11.3 Innovative Drug Market Challenges 11.4 Innovative Drug Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Innovative Drug Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Innovative Drug Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Innovative Drug Market Size Share by Region (2016-2021) Table 4. Global Innovative Drug Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Innovative Drug Forecasted Market Size Share by Region (2022-2027) Table 6. Global Innovative Drug Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Innovative Drug Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Innovative Drug Revenue Market Share by Type (2016-2021) Table 9. Global Innovative Drug Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Innovative Drug Revenue Market Share by Type (2022-2027) Table 11. Global Innovative Drug Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Innovative Drug Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Innovative Drug Revenue Market Share by Application (2016-2021) Table 14. Global Innovative Drug Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Innovative Drug Revenue Market Share by Application (2022-2027) Table 16. Global Innovative Drug Revenue (US$ Million) by Players (2016-2021) Table 17. Global Innovative Drug Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Innovative Drug as of 2020) Table 19. Date of Key Manufacturers Enter into Innovative Drug Market Table 20. Global Innovative Drug Top Players Headquarters and Area Served Table 21. Innovative Drug Product Solution and Service Table 22. Global Innovative Drug Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Pfizer Basic Information List Table 25. Pfizer Description and Business Overview Table 26. Pfizer Innovative Drug Products, Services and Solutions Table 27. Revenue (US$ Million) in Innovative Drug Business of Pfizer (2016-2021) Table 28. Pfizer Recent Developments Table 29. Roche Basic Information List Table 30. Roche Description and Business Overview Table 31. Roche Innovative Drug Products, Services and Solutions Table 32. Revenue (US$ Million) in Innovative Drug Business of Roche (2016-2021) Table 33. Roche Recent Developments Table 34. Sanofi Basic Information List Table 35. Sanofi Description and Business Overview Table 36. Sanofi Innovative Drug Products, Services and Solutions Table 37. Revenue (US$ Million) in Innovative Drug Business of Sanofi (2016-2021) Table 38. Sanofi Recent Developments Table 39. Johnson & Johnson Basic Information List Table 40. Johnson & Johnson Description and Business Overview Table 41. Johnson & Johnson Innovative Drug Products, Services and Solutions Table 42. Revenue (US$ Million) in Innovative Drug Business of Johnson & Johnson (2016-2021) Table 43. Johnson & Johnson Recent Developments Table 44. Merck & Co. (MSD) Basic Information List Table 45. Merck & Co. (MSD) Description and Business Overview Table 46. Merck & Co. (MSD) Innovative Drug Products, Services and Solutions Table 47. Revenue (US$ Million) in Innovative Drug Business of Merck & Co. (MSD) (2016-2021) Table 48. Merck & Co. (MSD) Recent Developments Table 49. Novartis Basic Information List Table 50. Novartis Description and Business Overview Table 51. Novartis Innovative Drug Products, Services and Solutions Table 52. Revenue (US$ Million) in Innovative Drug Business of Novartis (2016-2021) Table 53. Novartis Recent Developments Table 54. AbbVie Basic Information List Table 55. AbbVie Description and Business Overview Table 56. AbbVie Innovative Drug Products, Services and Solutions Table 57. Revenue (US$ Million) in Innovative Drug Business of AbbVie (2016-2021) Table 58. AbbVie Recent Developments Table 59. Gilead Sciences Basic Information List Table 60. Gilead Sciences Description and Business Overview Table 61. Gilead Sciences Innovative Drug Products, Services and Solutions Table 62. Revenue (US$ Million) in Innovative Drug Business of Gilead Sciences (2016-2021) Table 63. Gilead Sciences Recent Developments Table 64. GlaxoSmithKline (GSK) Basic Information List Table 65. GlaxoSmithKline (GSK) Description and Business Overview Table 66. GlaxoSmithKline (GSK) Innovative Drug Products, Services and Solutions Table 67. Revenue (US$ Million) in Innovative Drug Business of GlaxoSmithKline (GSK) (2016-2021) Table 68. GlaxoSmithKline (GSK) Recent Developments Table 69. Amgen Basic Information List Table 70. Amgen Description and Business Overview Table 71. Amgen Innovative Drug Products, Services and Solutions Table 72. Revenue (US$ Million) in Innovative Drug Business of Amgen (2016-2021) Table 73. Amgen Recent Developments Table 74. AstraZeneca Basic Information List Table 75. AstraZeneca Description and Business Overview Table 76. AstraZeneca Innovative Drug Products, Services and Solutions Table 77. Revenue (US$ Million) in Innovative Drug Business of AstraZeneca (2016-2021) Table 78. AstraZeneca Recent Developments Table 79. Bristol-Myers Squibb Basic Information List Table 80. Bristol-Myers Squibb Description and Business Overview Table 81. Bristol-Myers Squibb Innovative Drug Products, Services and Solutions Table 82. Revenue (US$ Million) in Innovative Drug Business of Bristol-Myers Squibb (2016-2021) Table 83. Bristol-Myers Squibb Recent Developments Table 84. Eli Lilly Basic Information List Table 85. Eli Lilly Description and Business Overview Table 86. Eli Lilly Innovative Drug Products, Services and Solutions Table 87. Revenue (US$ Million) in Innovative Drug Business of Eli Lilly (2016-2021) Table 88. Eli Lilly Recent Developments Table 89. Teva Basic Information List Table 90. Teva Description and Business Overview Table 91. Teva Innovative Drug Products, Services and Solutions Table 92. Revenue (US$ Million) in Innovative Drug Business of Teva (2016-2021) Table 93. Teva Recent Developments Table 94. Bayer Basic Information List Table 95. Bayer Description and Business Overview Table 96. Bayer Innovative Drug Products, Services and Solutions Table 97. Revenue (US$ Million) in Innovative Drug Business of Bayer (2016-2021) Table 98. Bayer Recent Developments Table 99. Novo Nordisk Basic Information List Table 100. Novo Nordisk Description and Business Overview Table 101. Novo Nordisk Innovative Drug Products, Services and Solutions Table 102. Revenue (US$ Million) in Innovative Drug Business of Novo Nordisk (2016-2021) Table 103. Novo Nordisk Recent Developments Table 104. Allergan Basic Information List Table 105. Allergan Description and Business Overview Table 106. Allergan Innovative Drug Products, Services and Solutions Table 107. Revenue (US$ Million) in Innovative Drug Business of Allergan (2016-2021) Table 108. Allergan Recent Developments Table 109. Takeda Basic Information List Table 110. Takeda Description and Business Overview Table 111. Takeda Innovative Drug Products, Services and Solutions Table 112. Revenue (US$ Million) in Innovative Drug Business of Takeda (2016-2021) Table 113. Takeda Recent Developments Table 114. Boehringer Ingelheim Basic Information List Table 115. Boehringer Ingelheim Description and Business Overview Table 116. Boehringer Ingelheim Innovative Drug Products, Services and Solutions Table 117. Revenue (US$ Million) in Innovative Drug Business of Boehringer Ingelheim (2016-2021) Table 118. Boehringer Ingelheim Recent Developments Table 119. North America Innovative Drug Market Size by Country (2016-2021) & (US$ Million) Table 120. North America Innovative Drug Market Size by Country (2022-2027) & (US$ Million) Table 121. Europe Innovative Drug Market Size by Country (2016-2021) & (US$ Million) Table 122. Europe Innovative Drug Market Size by Country (2022-2027) & (US$ Million) Table 123. Asia-Pacific Innovative Drug Market Size by Region (2016-2021) & (US$ Million) Table 124. Asia-Pacific Innovative Drug Market Size by Region (2022-2027) & (US$ Million) Table 125. Asia-Pacific Innovative Drug Market Share by Region (2016-2021) Table 126. Asia-Pacific Innovative Drug Market Share by Region (2022-2027) Table 127. Latin America Innovative Drug Market Size by Country (2016-2021) & (US$ Million) Table 128. Latin America Innovative Drug Market Size by Country (2022-2027) & (US$ Million) Table 129. Middle East & Africa Innovative Drug Market Size by Players (2016-2021) & (US$ Million) Table 130. Middle East & Africa Innovative Drug Market Size by Country (2022-2027) & (US$ Million) Table 131. Innovative Drug Market Trends Table 132. Innovative Drug Market Drivers Table 133. Innovative Drug Market Challenges Table 134. Innovative Drug Market Restraints Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Global Innovative Drug Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Innovative Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Innovative Drug Market Share by Regions: 2021 VS 2027 Figure 4. Global Innovative Drug Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Innovative Drug Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Innovative Drug Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Innovative Drug Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Innovative Drug Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Innovative Drug Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Innovative Drug Market Size Share by Type in 2021 & 2027 Figure 11. Biological Medicine Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Chemical Medicine Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Global Innovative Drug Market Size Share by Application in 2021 & 2027 Figure 14. Hospitals and Clinics Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Pharmacy Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Innovative Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 18. Global Top 5 and Top 10 Players Innovative Drug Market Share in 2020 Figure 19. North America Innovative Drug Market Share by Country (2016-2027) Figure 20. United States Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 21. Canada Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 22. Germany Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 23. France Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 24. U.K. Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 25. Italy Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 26. Russia Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 27. Nordic Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 28. Rest of Europe Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 29. Asia-Pacific Innovative Drug Market Share by Region (2016-2027) Figure 30. China Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 31. Japan Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 32. South Korea Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 33. Southeast Asia Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 34. India Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 35. Australia Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 36. Rest of Asia-Pacific Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 37. Latin America Innovative Drug Market Share by Country (2016-2027) Figure 38. Mexico Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 39. Brazil Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 40. Rest of Latin America Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 41. Middle East & Africa Innovative Drug Market Share by Country (2016-2027) Figure 42. Turkey Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 43. Saudi Arabia Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 44. UAE Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 45. Rest of Middle East & Africa Innovative Drug Market Size (2016-2027) & (US$ Million) Figure 46. Bottom-up and Top-down Approaches for This Report Figure 47. Data Triangulation

Pfizer Roche Sanofi Johnson & Johnson Merck & Co. (MSD) Novartis AbbVie Gilead Sciences GlaxoSmithKline (GSK) Amgen AstraZeneca Bristol-Myers Squibb Eli Lilly Teva Bayer Novo Nordisk Allergan Takeda Boehringer Ingelheim